US2017342085A1PendingUtilityA1
Antiviral compounds
Est. expiryMay 16, 2032(~5.8 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 31/12A61P 31/00A61P 31/14A61K 31/4188C07D 491/052A61P 1/16C07D 491/04A61K 38/21A61K 31/7072A61K 31/7056A61K 31/7068A61K 45/06C07D 413/14
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The disclosure is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
Claims
exact text as granted — not AI-modified1 - 33 . (canceled)
34 . A compound selected from:
or a pharmaceutically acceptable salt thereof.
35 . A pharmaceutical composition comprising the compound of claim 34 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable diluent or carrier, or combination thereof.
36 . The pharmaceutical composition of claim 35 , formulated for oral administration.
37 . The pharmaceutical composition of claim 35 , formulated in tablet form.
38 . A compound selected from:
39 . A pharmaceutical composition comprising the compound of claim 38 and a pharmaceutically acceptable diluent or carrier, or combination thereof.
40 . The pharmaceutical composition of claim 39 , formulated for oral administration.
41 . The pharmaceutical composition of claim 39 , formulated in tablet form.Join the waitlist — get patent alerts
Track US2017342085A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.